Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2569-75. doi: 10.1161/ATVBAHA.107.153692. Epub 2007 Oct 11.

Abstract

Objective: The mechanism and role of angiotensin II-induced vascular endothelial injury is unclear. We examined the molecular mechanism of angiotensin (AII)-induced vascular endothelial injury and its significance for hypertensive diastolic heart failure.

Methods and results: We compared the effect of valsartan and amlodipine on Dahl salt-sensitive hypertensive rats (DS rats). Valsartan improved vascular endothelial dysfunction of DS rats more than amlodipine, by inhibiting endothelial apoptosis and eNOS uncoupling more. Moreover, valsartan inhibited vascular apoptosis signal-regulating kinase 1 (ASK1) more than amlodipine. Thus, AT1 receptor contributed to vascular endothelial apoptosis, eNOS uncoupling, and ASK1 activation of DS rats. Using ASK1(-/-) mice, we examined the causative role of ASK1 in endothelial apoptosis and eNOS uncoupling. AII infusion in wild-type mice markedly caused vascular endothelial apoptosis and eNOS uncoupling accompanied by vascular endothelial dysfunction, whereas these effects of AII were absent in ASK1(-/-) mice. Therefore, ASK1 participated in AII-induced vascular endothelial apoptosis and eNOS uncoupling. Using tetrahydrobiopterin, we found that eNOS uncoupling was involved in vascular endothelial dysfunction in DS rats with established diastolic heart failure.

Conclusions: AII-induced vascular endothelial apoptosis and eNOS uncoupling were mediated by ASK1 and contributed to vascular injury in diastolic heart failure of salt-sensitive hypertension.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Acetophenones / therapeutic use
  • Amlodipine / pharmacology
  • Amlodipine / therapeutic use
  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Apoptosis* / drug effects
  • Biopterins / analogs & derivatives
  • Biopterins / pharmacology
  • Biopterins / therapeutic use
  • Blood Pressure
  • Calcium Channel Blockers / pharmacology
  • Calcium Channel Blockers / therapeutic use
  • Disease Models, Animal
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology
  • Heart Failure, Diastolic / drug therapy
  • Heart Failure, Diastolic / etiology
  • Heart Failure, Diastolic / metabolism*
  • Heart Failure, Diastolic / pathology
  • Heart Failure, Diastolic / physiopathology
  • Hydralazine / pharmacology
  • Hydralazine / therapeutic use
  • Hypertension / complications*
  • Hypertension / drug therapy
  • Hypertension / metabolism
  • Hypertension / pathology
  • Hypertension / physiopathology
  • MAP Kinase Kinase Kinase 5 / antagonists & inhibitors
  • MAP Kinase Kinase Kinase 5 / genetics
  • MAP Kinase Kinase Kinase 5 / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NADPH Oxidases / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Rats
  • Rats, Inbred Dahl
  • Receptor, Angiotensin, Type 1 / drug effects
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Signal Transduction
  • Sodium Chloride, Dietary / administration & dosage
  • Superoxides / metabolism
  • Tetrazoles / pharmacology
  • Tetrazoles / therapeutic use
  • Time Factors
  • Valine / analogs & derivatives
  • Valine / pharmacology
  • Valine / therapeutic use
  • Valsartan
  • Vasodilation

Substances

  • Acetophenones
  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Receptor, Angiotensin, Type 1
  • Sodium Chloride, Dietary
  • Tetrazoles
  • Superoxides
  • Angiotensin II
  • Amlodipine
  • Biopterins
  • Hydralazine
  • Valsartan
  • acetovanillone
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • NADPH Oxidases
  • MAP Kinase Kinase Kinase 5
  • sapropterin
  • Valine